Grant ID PP230043
Awarded On February 15, 2023
Title School-based Human Papillomavirus Vaccination Program in the Rio Grande Valley: Continuation and Expansion in Hidalgo, Cameron, and Willacy Counties
Program Prevention
Award Mechanism Primary Prevention of Cancer
Institution/Organization The University of Texas Medical Branch at Galveston
Principal Investigator/Program Director Abbey Berenson
Cancer Sites HPV-related
Contracted Amount $2,257,898
Lay Summary

Need: The human papillomavirus (HPV) vaccine serves as an effective primary prevention strategy [1] to reduce morbidity and mortality of HPV-associated diseases (cervical, oropharyngeal, vulvar, vaginal, penile, and anal cancers, and anogenital warts). However, there are an estimated 46,143 new cases of HPV-associated cancers diagnosed in the U.S. in each year [2] and estimated 4,280 HPV-associated cancer deaths from these cases. Moreover, the lifetime medical costs of diseases attributable to HPV infections acquired in 2018 surpass $770 million [3]. Morbidity, mortality, and direct costs could decrease if vaccination increased [4]. However, in 2020, only 61.4% of adolescent girls and 56.0% ...

Read More